Monday, September 21, 2026 • 06:51 AM
AI in Clinical Trials Faces New Pressure Over Real-Time Safety and Data Accuracy Clinical Trial Management
AI in Clinical Trials Faces New Pressure Over Real-Time Safety and Data Accuracy

By Editorial Panel, Pharma Business Outlook, Editor

J&J’s Heart Pump Study Offers New Hope for High-Risk Cardiac Surgery Patients Clinical Trial Management
J&J’s Heart Pump Study Offers New Hope for High-Risk Cardiac Surgery Patients

By Editorial Panel, Pharma Business Outlook, Editor

Connecting the Dots in Specialty Care Pharmacy Management
Connecting the Dots in Specialty Care

By Editorial Panel, Pharma Business Outlook, Editor

Amazon Steps Into Drug Discovery With an AI-Powered Molecule Design Platform Drug Discovery and Development
Amazon Steps Into Drug Discovery With an AI-Powered Molecule Design Platform

By Editorial Panel, Pharma Business Outlook, Editor

ImmuneOncia and Lonza Join Hands to Advance Cancer Treatment Innovation Drug Discovery and Development
ImmuneOncia and Lonza Join Hands to Advance Cancer Treatment Innovation

By Editorial Panel, Pharma Business Outlook, Editor

FDA Approves Foundayo, A Game-Changing Daily Pill for Weight Management Drug Discovery and Development
FDA Approves Foundayo, A Game-Changing Daily Pill for Weight Management

By Editorial Panel, Pharma Business Outlook, Editor

Galenica AG Balances Stability and Change in a Digital Healthcare Era Pharmacy Management
Galenica AG Balances Stability and Change in a Digital Healthcare Era

By Editorial Panel, Pharma Business Outlook, Editor

Rethinking Pharmacy Benefits: How AffirmedRx Is Changing the PBM Landscape Pharmacy Management
Rethinking Pharmacy Benefits: How AffirmedRx Is Changing the PBM Landscape

By Editorial Panel, Pharma Business Outlook, Editor

Global Crackdown Targets Illegal Online Pharmacies Selling Fake Medications Pharmacy Management
Global Crackdown Targets Illegal Online Pharmacies Selling Fake Medications

By Editorial Panel, Pharma Business Outlook, Editor

Lilly expands Zepbound access with new once-monthly injection pen Pharmacy Management
Lilly expands Zepbound access with new once-monthly injection pen

By Editorial Panel, Pharma Business Outlook, Editor

Kroger Expands Weight Management Care With Access to Popular GLP-1 Drugs Pharmacy Management
Kroger Expands Weight Management Care With Access to Popular GLP-1 Drugs

By Editorial Panel, Pharma Business Outlook, Editor

New trial shows embolization sharply lowers risk in mild subdural hematoma Clinical Trial Management
New trial shows embolization sharply lowers risk in mild subdural hematoma

By Editorial Panel, Pharma Business Outlook, Editor

Deep Intelligent Pharma Raises Fresh $60 Million to Take AI Into Clinical Trials Drug Discovery and Development
Deep Intelligent Pharma Raises Fresh $60 Million to Take AI Into Clinical Trials

By Editorial Panel, Pharma Business Outlook, Editor

When Winter Viruses Rise, Human Care Makes the Difference Pharmacy Management
When Winter Viruses Rise, Human Care Makes the Difference

By Editorial Panel, Pharma Business Outlook, Editor

Axol Bioscience Secures $2.8M Funding to Expand US Growth and Scale iPSC Disease Models Drug Discovery and Development
Axol Bioscience Secures $2.8M Funding to Expand US Growth and Scale iPSC Disease Models

By Editorial Panel, Pharma Business Outlook, Editor

Conceiving a Unique Biological Lowdown to Holistically Enhance Healthcare Pharmacy Management
Conceiving a Unique Biological Lowdown to Holistically Enhance Healthcare

By Editorial Panel, Pharma Business Outlook, Editor

Pharma Business Outlook

Pharma Business Outlook is more than just a publication—it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem.